Founder, Chairman of the Board

Iantrek raises $42M for Alloflo Uveo glaucoma therapy launch

Iantrek Raises $42M in Series C for Glaucoma Treatment Device

Iantrek: $42 Million Series C Raised For Interventional Glaucoma Therapy

Iantrek Raises $42 Million Series C

Regional Sales Director - Southeast

IANTREK is committed to meaningful innovation in glaucoma care, developing next-generation bio & micro-interventional technologies. The Regional Sales Director will lead the expansion of IANTREK’s ophthalmic surgical portfolio, overseeing Surgical Glaucoma Managers to drive commercial growth and clinical adoption.

Sign up with Google

Sign in with Google